July 29, 2016 Tourism and insurance

Company Rating (common and preferred shares) Adris Grupa Under review

All segments delivered strong numbers Reuters: ADGR.ZA (ADGR_p.ZA) Bloomberg: ADRSRA CZ (ADRSPA CZ) ZSE: ADRS-R-A (ADRS-P-A)

Adris' (ADRS) top line was cut by 27.9% yoy in 2Q16 to HRK985m, while overall sales in 1H16 fell by 28.7% yoy as TDR dropped out of Adris’ COMMON SHARES financials from 4Q15 onwards. As the company had these M&A Last price (HRK) 552 activities on both buy and sell sides last year, comparability is Price target (HRK) N/A limited. Nevertheless, all the three strategic business segments Previous target (HRK) N/A recorded positive performance in 1H16. Adris’ tourist arm Maistra saw 12-month range (HRK) 459-584 6.1% yoy higher sales in 1H16 thanks to 8% yoy higher ADR, despite 12-month volatility 29% tourist overnights down by 3%. Another strong tourist season is Free float 50% expected as current booking implies positive trends and ADR growth, mostly on the back of investments (HRK400m in 2016) in hotels in PREFERRED SHARES camps. Fish production segment (Cromaris) recorded 11% yoy higher Last price (HRK) 402 sales volumes in 1H16which along with 6% yoy higher average fish Price target (HRK) N/A prices led to 18% yoy higher top line. Meanwhile, export grew by 16% Previous target (HRK) N/A and is still the foot-hold of Cromaris’ business model as 80% of total 12-month range (HRK) 329-435 sales are exported mainly to Italy. Finally, insurance business 12-month volatility 22% Osiguranje delivered 0.7% yoy higher GWP of HRK1.8bn on the back of Free float 82% health insurance along with positive effects after the first phase of restructuring finished. At the same time, CO managed to maintain Total market capitalization (HRKm) 8.035 leading position in the Croatian insurance market with 0.4pp qoq higher market share of 32.9%. However, further price war in motor insurance segment is a major downside risk on financial results. Stock price performance 800 7000 ADRS -P-A (HRK, lhs) All said, recent M&A activities helped profitability as EBITDA improved 700 6000 ADRS -R-A (HRK, lhs) 600 by 12.2% yoy to HRK287m in 2Q16 while EBITDA margin went up by CROBEX (rhs) 5000 500 5.8pp to 21.9%. These numbers are easily translated in 1H16 figures as 4000 400 EBITDA soared 17.7% yoy which led to 5.1pp improvement in EBITDA 3000 300 2000 margin that stands at 14.2%. Finally, positive financial result of 200 HRK45m helped the net profit that managed to stay around last year’s 100 1000 Source: ZSE, HAAB Research level of HRK151m despite TDR sale. Finally, net profit managed to 0 0 Jan -07 May -09 Sep -11 Jan -14 May -16 stay around last year’s level of HRK151m despite TDR sale. Looking more closely at Adris unconsolidated financial reports we see cca HRK100m (+73.8% yoy) yoy higher other revenues implying this one-off largely helped net profit. Quarterly profits (HRKm)

400 EBITDA Source: Company data, HAAB Research Looking ahead, in the next three years Adris is planning to invest HRK 300 EBIT 4bn in tourism, health food and regionalization of insurance business. 200 All in all, we keep our target price and recommendation UNDER 100 0 REVIEW given the needed adjustments to the model after BAT’s -100 acquisition of TDR and inclusion of CO and due to changes of analyst -200 and development of new valuation model. -300 -400 -500 4Q12 2Q13 4Q13 2Q14 4Q14 2Q15 4Q15 2Q16

Hrvoje Stojić Analyst (+385) 1 603 0509 [email protected]

SEE THE DISCLOSURES APPENDIX FOR IMPORTANT DISCLOSURES AND ANALYST CERTIFICATION July 29, 2016

Adris Grupa

Quarterly Income Statement

HRKm 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 All segments delivered strong numbers 594 482 695 1.026 511 447 1.141 1.710 1.152 1.138 1.366 1.791 863 801 985 Other revenues 33 12 23 22 35 23 111 145 175 201 220 110 192 90 325 Operating revenues 626 494 718 1.048 546 469 1.252 1.856 1.327 1.338 1.586 1.901 1.055 891 1.311 Operating expenses -533 -438 -561 -675 -522 -434 -1.093 -1.563 -1.520 -1.333 -1.326 -2.264 -1.300 -868 -1.026 EBITDA 91 56 158 373 32 35 164 298 -127 9 256 -354 -186 25 287 Depreciation -191 -96 -94 -92 -79 -70 -79 -84 -85 -82 -84 -86 -106 -71 -70 EBIT -100 -40 64 281 -47 -35 85 214 -212 -73 172 -440 -292 -47 217 Net financial result 106 87 -3 97 30 74 82 174 92 124 0 2.996 -497 -32 77 Associates & extraordinaries 20 0 0 0 23 0 2 3 22 3 4 3 -10 3 3 Pre-tax profit 28 47 61 378 -2 39 164 385 -164 49 180 2.551 -859 -77 294 Tax 22 -42 -28 -28 -1 -27 -21 -23 -2 -31 -49 125 -572 0 -66 Net profit 50 5 33 350 -3 12 143 362 -166 19 131 2.676 -1.431 -77 228

Growth (%, yoy) 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 Sales n/a -0,8 -5,8 -3,3 -14,0 -7,3 64,1 66,6 125,6 154,7 19,7 4,7 -25,1 -29,6 -27,9 Other revenues n/a -37,5 1,4 -8,9 8,5 87,1 382,1 571,4 395,3 778,1 97,8 -24,2 9,5 -55,1 47,6 Operating revenues n/a -2,2 -5,6 -3,4 -12,8 -5,0 74,3 77,0 143,1 185,1 26,7 2,5 -20,5 -33,4 -17,4 Operating expenses n/a 2,7 -7,8 -3,5 2,1 0,8 -94,9 -131,7 -191,0 -207,0 -21,4 -44,8 14,5 34,9 22,6 EBITDA n/a -28,9 3,4 -3,1 -65,2 -37,7 4,2 -20,3 -499,6 -74,3 55,9 -218,9 -46,7 172,7 12 Depreciation n/a 48,5 43,4 33,1 58,7 27,4 15,4 9,0 -7,2 -17,6 -5,4 -3,0 -25,2 13,4 15,9 EBIT n/a -372,0 -26,7 -11,0 52,7 12,7 33,0 -24,0 -347,4 -110,6 103,1 -305,7 -38,1 36,4 26 Net income n/a -82,4 -68,0 9,3 -71,6 -14,7 3.378 78,7 204,5 67,0 -100,0 1.625 -642,6 -125,5 n/a

Profitability (%, ttm) 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 EBITDA margin 23,8 23,2 23,7 23,6 21,8 21,2 17,8 12,4 6,0 4,6 6,0 n/a -5,8 -6,0 -5,8 EBIT margin 10,7 8,9 8,3 7,2 8,9 9,2 8,2 4,8 -0,5 -1,1 0,5 n/a -11,9 -12,4 -12,3 Net profit 16,9 16,2 14,0 15,2 13,7 14,1 15,2 12,5 7,2 6,2 5,7 43,2 23,7 23,9 27,1 ROA 5,6 5,3 4,5 4,7 4,1 4,2 4,5 4,0 2,4 2,2 1,9 14,3 7,4 6,8 7,2 ROE 6,8 6,4 5,4 5,7 5,0 5,0 6,3 6,2 4,1 4,1 3,8 28,1 14,6 13,5 14,3

Leverage (ttm) 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 Assets/Equity 1,2 1,2 1,3 1,2 1,2 1,2 2,0 1,9 2,0 2,0 2,0 1,9 2,0 2,0 2,0 Net debt/Equity 0,0 0,0 0,1 0,1 0,0 0,0 0,0 0,0 0,0 0,0 0,0 -0,4 0,0 0,0 0,0 Net debt/EBITDA 0,5 0,4 1,0 0,7 0,6 0,6 0,5 0,4 0,6 1,0 0,0 14,0 0,0 0,2 -1,3

Valuation (ttm) 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 P/S 1,0 1,1 1,1 1,0 1,1 1,0 0,9 0,9 0,8 0,7 0,9 0,8 1,0 1,0 1,1 P/EBITDA 3,9 4,5 4,5 4,0 4,9 4,5 4,9 6,9 12,1 14,6 12,6 -15,2 -15,4 -15,2 -16,5 P/EBIT 8,6 11,7 13,0 13,3 11,9 10,4 10,6 17,6 n/a n/a 154,5 n/a n/a n/a n/a P/E 5,4 6,5 7,7 6,3 7,7 6,7 5,7 6,8 10,1 10,8 13,3 1,7 3,8 3,8 3,6 P/B 0,4 0,4 0,4 0,3 0,4 0,3 0,3 0,4 0,4 0,4 0,5 0,4 0,5 0,5 0,5 EV/Sales 1,1 1,2 1,4 1,2 1,2 1,1 1,0 1,0 0,8 0,8 0,9 0,1 1,0 1,0 1,2 EV/EBITDA 4,3 5,0 5,5 4,8 5,5 5,1 5,3 7,2 12,7 15,6 12,6 -1,2 -15,4 -15,0 -17,8 EV/EBIT 9,7 12,9 15,9 15,6 13,4 11,7 11,7 18,5 n/a n/a 154,3 n/a n/a n/a n/a

Source: unaudited financial reports, HAAB research

Page 2 July 29, 2016

Adris Grupa

FY Financial Statements

Income Statement (HRKm) 2012 2013 2014 2015 Sales 2.879 2.714 4.462 5.158 Other revenues 99 92 426 723 Operating revenues 2.977 2.807 4.889 5.881 Operating expenses -2.268 -2.196 -4.610 -6.224 EBITDA 710 611 279 -343 Depreciation -391 -361 -351 -358 EBIT 319 250 -72 -702 Net financial result 259 212 410 2.623 Associates & extraordinaries 20 23 26 0 Pre-tax profit 599 485 365 1.921 Tax -95 -99 -43 -527 Net profit 504 386 322 1.394

Balance Sheet (HRKm) 2012 2013 2014 2015 Cash 61 46 221 167 Inventories 694 832 821 368 Accounts receivable 377 362 977 595 Intangible assets 162 169 1.040 873 Property, plant and equipment 3.010 2.971 4.105 3.394 Other assets 4.652 5.133 10.889 13.789 Total assets 8.956 9.512 18.054 19.185 Accounts payable 317 198 243 139 Short-term debt 333 336 259 29 Long-term debt 70 78 143 132 Equity 7.668 7.898 9.254 9.639 Net debt 343 368 180 -5

Cash Flow Statement (HRKm) 2012 2013 2014 2015 Operating cash flow 309 627 704 3.892 Net capital expenditures -334 -421 -353 -615 Net increase in debt -3 19 -107 141 Dividends paid -112 -101 -128 -954 Other investing/financing cash flow 43 -139 191 4.078 Net cash flow -97 -15 308 6.541 Change in working capital -528 -221 7.481 -6.597

Growth (%) 2012 2013 2014 2015 Sales 64,1 -5,7 64,4 15,6 EBITDA 325,1 -13,9 -54,3 -223,1 EBIT n/a -21,8 -128,7 n/a

Profitability (%) 2012 2013 2014 2015 EBITDA margin 23,8 21,8 5,7 -5,8 EBIT margin 10,7 8,9 -1,5 -11,9 Net profit 16,9 13,7 6,6 23,7 ROA 5,6 4,2 2,3 7,5 ROE 6,6 5,0 3,7 14,8

Leverage 2012 2013 2014 2015 Assets/Equity 1,2 1,2 2,0 2,0 Net debt/Equity 0,0 0,0 0,0 0,0 Net debt/EBITDA 0,5 0,6 0,6 0,0

Source: unaudited financial reports, HAAB research

Page 3 July 29, 2016

Disclosures Appendix

The information and opinions in this report/investment research were prepared by Addiko Bank d.d. and/or one or more of its subsidiaries/affiliates (collectively, 'Addiko Bank') for information purposes only. This report is not investment advice or an offer or solicitation for the purchase or sale of any security/financial instrument or to participate in any trading strategy. Neither Addiko Bank nor any of its employees accept any liability for any direct or consequential loss arising from any use of this publication or its contents. Any investments referred to herein may involve significant risk, are not necessarily available in all jurisdictions, may be illiquid and may not be suitable for all investors. The value of, or income from, any investments referred to herein may fluctuate in price and value. Past performance is not indicative of future results. Besides, the risks associated with an investment in the financial, money market or investment instrument or security under discussion are not explained in their entirety. Estimates of future performance are based on assumptions that may not be realized. Investors should make their own investment decisions without relying on this publication. Only investors with sufficient knowledge and experience in financial matters to evaluate the merits and risks should consider an investment in any issuer or market discussed herein and other persons should not take any action on the basis of this publication.

This report is based on information available to the public. While reasonable care has been taken to ensure that the information contained herein is not untrue or misleading at the time of publication, Addiko Bank makes no representation or guarantee with regards to the accuracy, completeness or suitability of the data. Addiko Bank does not undertake to advise you of changes in its opinion or information. Moreover, we reserve the right not to update this information or to discontinue it altogether without notice. From time to time our analysts receive assistance from the issuer including, but not limited to, discussions with management of the subject company(ies). Addiko Bank policy prohibits research analysts from sending draft research including recommendations (rating, target price) and summary to subject companies. However, it should be presumed that the author(s) have communicated with the subject company to ensure factual accuracy of the (company) research report prior to publication, without mentiong recommendation and summary. Facts and views presented in Addiko research reports have not been reviewed by, and may not reflect information known to, professionals in other Addiko business units, including investment banking / treasury / corporate personnel. Any opinions and estimates contained herein reflect the current judgment of the author(s) and do not necessarily reflect the opinion of Addiko Bank or any of its subsidiaries and affiliates.

This report is disseminated and available primarily electronically to professional clients and eligible counterparties, who are expected to make their own investment decision without undue reliance on this publication, and may not be sold, redistributed, reproduced or published in whole or in part for any purpose without the prior express consent of Addiko Bank. Please always cite source when quoting. Additional information is available on request. Clients should contact and execute transactions through a Addiko Bank d.d. or group entity in their home jurisdiction unless local regulations permit otherwise.

Addiko Bank and others associated with it may be involved or seek to be involved in many businesses that may relate to companies, issuers or instruments mentioned in this report. These businesses include market making, providing liquidity and specialized trading and other proprietary trading, fund management, investment services and investment banking. Addiko Bank and others associated with it including any of its employees may have positions in securities of companies or financial instruments discussed in Addiko research, and may trade them in ways different from those discussed in this report, i.e. they are not obliged to act in accordance with investment recommendation from Addiko research.

POTENTIAL CONFLICTS OF INTEREST

Disclosures of interest and conflicts of interest relating to Addiko Bank and/or affiliate with respec to to the analyzed company, financial instruments and/or securities forming the subject to this document ar valid as of the end of the month prior to publication of this document*:

HT 6; 6; 6; Belje 6; 8; 8; 8;

1. Addiko Bank and/or affiliate (pursuant to relevant domestic law) owns at least 1% of the company's share capital. 2. The analyzed company owns more than 1% of the issued share capital of Addiko Bank and/or affiliate (pursuant to relevant domestic law). 3. Addiko Bank and/or affiliate (pursuant to relevant domestic law) administers the securities of the analyzed company by quoting bid and ask prices (i.e. acts as a market maker or liquidity provider in the securities of the analyzed company) 4. Addiko Bank and/or affiliate acted as a manager or co-manager of a public offering of securities of the analyzed company within 12 months preceding this publication 5. Addiko Bank and/or affiliate has agreed to render other investment banking services for the analyzed company within 12 months preceding this publication, in return for which the Bank received a consideration or promise of consideration. 6. The research analyst(s) own securities of the company analyzed by him or her. 7. The research analyst(s) are on the supervisory/management board of the company they cover. 8. Addiko Bank and/or affiliate extended significant amount of credit facilities to the analyzed company. 9. The research analyst(s) have received or bought securities of the analyzed company before the launch of public offering of the company * Updating this information may take up to five working days after month end.

EQUITY RECOMMENDATION DEFINITIONS, VALUATION METHODS AND PRINCIPLES

Readers may find the history of changes to recommendation definitions on our website: https://www.addiko.hr/ under the heading 'Economic Research / Disclaimer'.

We currently use a five-tier recommendation system for the stocks in our formal coverage: Buy, Add, Hold, Reduce or Sell (see definitions below): Buy: Expected total return (including dividends) of at least 20% over a 12-month period; Add: Expected total return (including dividends) of 10% to 20% over a 12-month period; Hold: Expected total return (including dividends) of -10% to 10% over a 12-month period; Reduce: Expected total return (including dividends) of -20% to -10% over a 12-month period; Sell: Expected total return (including dividends) of -20% or worse over a 12-month period;

Research published prior to 31/12/2008 were based on the following three-tier recommendation system: Buy: Expected total return (including dividends) of 15% or more over a 12-month period; Hold: Expected total return (including dividends) between -15% and 15% over a 12-month period; Sell: Expected total return (including dividends) of -15% or worse over a 12-month period.

We use two other categorizations for stocks in our coverage:

Restricted: The coverage of the company has been suspended temporarily due to market events that make coverage impracticable or to comply with applicable regulations and/or firm policies in certain circumstances including where Addiko Bank is acting as an advisor in a merger or strategic transaction involving the company. Under review: Financial forecasts and/or target are not disclosed owing to circumstances such as changes in the research team and other market events that require additional efforts to determine the value of the company based on the used valuation methods. July 29, 2016

Our company valuations are based on but not limited to the following valuation methods: Multiple-based models (P/E, P/cash flow, EV/sales, EV/EBIT, EV/EBITA, EV/EBITDA, etc.), peer-group comparisons, historical valuation approaches (e.g acquisition multiple comparisons), discount models (DCF, DVMA, DDM), break-up value approaches or asset-based evaluation methods. Furthermore, recommendations may be also based on the Economic profit approach. Although the definition and application of these methods are based on generally accepted industry practices and models developed in the financial economics literature, please note that there is a range of reasonable variations within these models. Valuation models are dependent on macroeconomic factors, such as interest rates, exchange rates, commodities, and on assumptions about the economy that are subject to uncertainty and also may change over time. Any valuation is dependent upon inputs that are based on the subjective opinion of the analysts carrying out this valuation. Investors and other recepients of this research may request further information and details with respect to the valuation models or assumptions applied to the models. Furthermore, market sentiment and the overall liquidity situation affect the valuation of companies. The valuation is also based on expectations that might change rapidly and without notice, depending on industry-specific developments. Our recommendations and target prices derived from the models might consequently change accordingly. Recommendations generally relate to a 12- month horizon. They are, however, also subject to market conditions and can only represent a snapshot. The ratings may in fact be achieved more quickly or slowly than expected, or need to be revised upward or downward.

This report may include research based on technical analysis. Technical analysis is generally based on the study of trading volumes and price movements in an attempt to identify and project price trends. Technical analysis does not consider the fundamentals of the underlying issuer or instrument and may offer an investment opinion that conflict with other research generated by Addiko Bank. Investors may consider technical research as one input in formulating an investment opinion. Additional inputs should include, but are not limited to, a review of the fundamentals of the underlying issuer/security/instrument.

Distribution of recommendations

Number of recommendations from Addiko Bank, Economic Research Department, at 31.12.2015 Broken down by categories

2 (25%) Buy / Add 1 (13%) Hold 0 (0%) Sell / Reduce 6 (63%) Under review 0 (0%) Restriction thereof recommendations for companies to which investment banking services were provided during the preceding twelve months - Buy / Add - Hold - Sell / Reduce

Coverage policy

A list of the companies covered by Addiko Bank is available upon request.

Frequency of reports and updates

Although it has not been determined in advance whether and in what intervals this report will be updated, if the publication is a fundamental research report, it is our intention that each of these companies are covered at least once a year, in the event of key operations and/or changes in the recommendation, subject to applicable quiet periods and capacity constraints.

SIGNIFICANT FINANCIAL INTEREST:

Addiko Bank and/or affiliate (pursuant to relevant domestic law) regularly trade shares of the analyzed company(ies). Addiko Bank and/or affiliate (pursuant to relevant domestic law) acts as a market maker in government bonds issued by the Croatian Ministry of Finance (Treasury).

ANALYST CERTIFICATION

The research analyst(s) or analysts who prepared this report (see the first page) hereby certifies that: (1) the views expres sed in this report accurately reflect their personal views about the subject securities or issuers and/or other subject matter as appropriate; and, (2) no part of his or her compensation was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this report. On a general basis, the efficacy of recommendations and clients' feedback are factors in the performance appraisals of analysts.

ORGANIZATIONAL AND ADMINISTRATIVE ARRANGEMENTS TO AVOID AND PREVENT CONFLICTS OF INTEREST

To prevent or remedy conflicts of interest arising as a result of the preparation and publication of research, Addiko Bank has established the organizational arrangements required from a legal and supervisory aspect, adherence to which is monitored by Addiko Bank Compliance and Security Department. Conflicts of interest arising as a result of the preparation and publication of research are managed through its use of internal databases, notifications by the relevant employees as well as legal and physical and non-physical barriers (collectively referred to as 'Chinese Walls') designed to restrict the flow of information between one area/department of Addiko Bank and another. In particular, Investment Banking units, including corporate finance, capital market activities, financial advisory and other capital raising activities, are segregated by physical and non-physical boundaries from Markets Units, as well as the research department. For further details see our Policy for managing conflicts of interest in connection with investment research at http://www.addiko.com/bank/dokumenti/Politika_sukob_interesa.pdf

Addiko Bank d.d. is regulated by the Croatian Financial Services Supervisory Agency (HANFA) for the conduct of designated investment business in Croatia. COMMON SHARE Date Rating Target price 20.05.2008 Buy HRK684 18.09.2009 Hold HRK325 ADRS-R-A (common share) 700 25.01.2011 Hold HRK328 02.08.2011 Hold HRK308 07.03.2012 N/A U/R 21.12.2012 Add HRK293 19.02.2014 N/A U/R 500 03.11.2014 N/A U/R 03.08.2015 N/A U/R 03.11.2015 N/A U/R 02.03.2016 N/A U/R 300 2.5.2016 N/A U/R 29.7.2016 N/A U/R

Source: Bloomberg, HAAB Research PREFERRED SHARE 100 Date Rating Target price 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 02.04.2008 Buy HRK517 20.05.2008 Buy HRK558 600 18.08.2008 Buy HRK559 18.09.2009 Buy HRK361 ADRS-P-A (preferred share) 25.01.2011 Buy HRK365 500 02.08.2011 Buy HRK343 07.03.2012 N/A U/R 21.12.2012 Buy HRK325 400 31.01.2013 Add HRK325

31.07.2013 Add HRK325 300 19.02.2014 N/A U/R 03.08.2015 N/A U/R 03.11.2015 N/A U/R 200 02.03.2016 N/A U/R 2.5.2016 N/A U/R Source: Bloomberg, HAAB Research 100 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016